Ongoing Study of Obinutuzumab Short Duration Infusion in Patients with Previously Untreated Advanced Follicular Lymphoma
Author(s) -
Miguel Canales,
Thomas A. Buchholz,
James R. Mason,
Joana Parreira,
Monique S Tomiczek,
Kai Hübel
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-123638
Subject(s) - medicine , obinutuzumab , tolerability , follicular lymphoma , lymphoma , rituximab , oncology , surgery , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom